Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 21 results for "gotemba"

"Fuel Cell System and Control Method Thereof" in Patent Applic...

By a News Reporter-Staff News Editor at -- A patent application by the inventors KAWAHARA, Shuya (Gotemba-shi, Sizuoka-ken, JP); SUEMATSU, Keigo ( Toyota -shi, Aichi-ken, JP); TOIDA, Masashi ( Nagoya -shi, Aichi-ken, JP); AKABOSHI, Ryota ( Toyota ... Equities.com, 1 month ago

Researchers Submit Patent Application, "Drive System for Hybrid Vehicle", for Approval (USPTO 20160107518)

By a News Reporter-Staff News Editor at Politics & Government Week -- From Washington, D.C., VerticalNews journalists report that a patent application by the inventors OKUWAKI, Shigeru (Gotemba-shi, Shizuoka-ken, JP); SHIOIRI, Hiroyuki (Numazu-shi, ...
 Equities.com14 hours ago Patent Issued for Control Device for Internal Combustion Engine (USPTO 9316163)  Equities.com1 week ago Patent Issued for Spectrum Measurement Device (USPTO 9305220)  Equities.com3 weeks ago

Ricoh Eco Business Development Center Opens

Few Sec ago The " Ricoh Eco Business Development Center" , established by Ricoh Company, Ltd. (President, Corporate Executive Officer: Zenji Miura) with the aim of creating and expanding new businesses based on environmental sustainability, opens ...
 India Online.in1 day ago Ricoh opens Eco Business Development Centre  The Recycler2 weeks ago RICOH : Eco Business Development Center Opens  4 Traders3 weeks ago
Eco-Business

Eco Action Day marks 10 years of environmental leadership

A 100 per cent renewable energy-powered Ricoh billboard in Ginza district in Tokyo, Japan. The company has mooted the global Eco Action Day since 2006 to get its employees, partners, and customers to take actions to reduce their environmental ...
 Eco-Business1 week ago

CHUGAI PHARMACEUTICAL : and TWO CELLS Announce a License Agreement for "gMSC®1," a Regenerative Cellular Medicine for Chondrogenesis in the Knee

-- Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; Chairman & CEO: Osamu Nagayama] (Chugai) and TWO CELLS Co., Ltd. [Head Office: Hiroshima-shi, Hiroshima; President & CEO: Ko-ichiro Tsuji] (TWO CELLS) announced that on April 25, 2016, ...
 4 Traders1 week ago Chugai and TWO CELLS Announce a License Agreement for "gMSC1," a Regenerative Cellular Medicine for Chondrogenesis in the Knee  FirstWord Pharma1 week ago
Business Insider

Japan public divided as laws easing limits on military take effect

Japanese Ground Self-Defense Force soldiers ride on a 203mm self-propelled howitzer during an annual training session, which is based on a scenario to defend or retake islands in Japanese territory, near Mount Fuji at Higashifuji training field in ...
 Business Insider1 month ago

Staying at a love hotel in Japan, right in the middle of Osaka. And about the presidential suite of a love hotel.

So last night, there we were in Tokyo having an aged beef steak degustation dinner with old friends from Manila, catching up on news and living a #Travelife . Just like about 50 other friends and relatives, they're here for the Holy Week break . I ...
 Travelife Magazine1 month ago
The Japan News

NPA to test higher speed limit on expwys

Jiji Press TOKYO (Jiji Press) — The National Police Agency has decided to test a higher speed limit on some sections of the Shin-Tomei Expressway and the Tohoku Expressway, NPA officials said Thursday. The speed limit will be raised to 110 kph ...
 The Japan News1 month ago
Nikkei Asian Review

Tasmania's liquid gold rush picks up speed

HOBART, Australia -- "Liquid gold" is how aficionados describe the very best single malt whiskies. Over the last five years, a growing number of enthusiasts have made the long trek to the Australian island state of Tasmania to sample what experts ...
 Nikkei Asian Review1 month ago

Chugai Announces Phase II Global Study Results of Nemolizumab (CIM331) in Late-breaking Research Forums at AAD

Details Category: Antibodies Published on Monday, 07 March 2016 08:30 Hits: 22 - Efficacy and Tolerability in Atopic Dermatitis were Observed - TOKYO, Japan I March 6, 2016 I Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the ...
 PipelineReview1 month ago Chugai Pharma Announces Phase II Global Study Results Of Nemolizumab (CIM331) In Late-Breaking Research Forums At  BioSpace1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gotemba
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less